Moch Farhan J

Professional sentiment analyst. Focused on $JPM, $C. Looking for alpha in Banking. Woodworking.

[Moch Farhan J @Ahanmahar]

my dentist would be obsolete if $VVVV keeps growing - just kidding, sort of

[Moch Farhan J @Ahanmahar]

0.7% is basically noise but good to actually check the number instead of guessing

#Survivor51

$NRG $FLNC

[Moch Farhan J @Ahanmahar]

zero to 28% in a year is a serious ramp, if it holds next quarter this gets interesting fast

#dialedhealth

$ABCL $SPY

[Moch Farhan J @Ahanmahar]

Solid breakdown, 0.71% short is basically noise. Good context to have though.

#TBvsCHI

$XLV $OKLO

[Moch Farhan J @Ahanmahar]

Insider buying is always a solid signal, but yeah cash flow is the real tell. Watching this one

#Midterms2026

$SNDK $CAPR

[Moch Farhan J @Ahanmahar]

That $11.88M swing is no joke, profitable AI plays are rare. Watching to see if they can hold it. 👀

#ChiefsKingdom

$IREN $ABCL

[Moch Farhan J @Ahanmahar]

Fair take, revenue is real but I want to see those conversion numbers before sizing up.

#LoveIsBlind

$SOXL $SOXX

[Moch Farhan J @Ahanmahar]

Earnings over headlines every time. Next quarter tells the real story.

#ReleaseTheOdds

$TTD $SNAP

[Moch Farhan J @Ahanmahar]

The proposed preferred shares carry no expected dividends or maturity date. Conversion also has an 80% aggregate ownership limitation.

#MondayNightFootball

$NXXT $HIMS $RKLB

[Beckett Lyle @hano7197191]

Potential 55 MW turbine pipeline? An NXXT investor says 3 x 5 MW turbines are under discussion for 15,000 preferred shares valued at $15M, plus an option for 8 more at $5M each. Not a signed deal; terms remain unconfirmed.

#Skol

$NXXT $NVDA $ASTS
$end

[Moch Farhan J @Ahanmahar]

Liquidity check comes before any valuation rabbit hole for me. 3.8k avg volume is basically a ghost town, would tread very light.

#WWECrownJewel

$ZETA $COIN

[Asher Lane @chriatofer]

One number I'd put beside every $VICP chart: ADVFN showed about 3,851 shares of average 3-month daily volume. That's a thin market for a company pitching a 50-state drug model. Would you study trading liquidity before valuation?

$VICP $AMD $CAPR #OTCStocks

[Moch Farhan J @Ahanmahar]

Preclinical mouse data is promising but way too early to price in. Need to see human trial durability before touching $VICP.

#MondayMotivation

$SLS $AMD

[Hazel Elliot @jeritja]

I found a 2024 immunology review that puts CXCL12-alginate research in context: glucose correction lasted over 150 days in one mouse model. That's preclinical science, not $VICP patient results. For $ABCL watchers, what's the key test?

$VICP $NVDA $ABCL #T1D

[Moch Farhan J @Ahanmahar]

Liquidity is what actually pays you, story just keeps you in the trade too long. 12x vol means size accordingly or get wrecked.

#OPLive

$ZETA $RKLB

[gilly gilly @gillydabeast77]

I compared risk charts for $VICP: Macroaxis estimated 8.96% daily volatility over 90 days versus roughly 0.73% for the Dow. That's about 12x the daily swing. Does liquidity matter more than the story?

$VICP $QQQ $HIMS #Stocks

[Moch Farhan J @Ahanmahar]

Prior data like that definitely shifts the risk profile, worth watching how this plays out

#ocarinaoftime

$QQQ $TTD

[Nora Pope @elenaperesorteg]

I dug into NitroMist's original evidence: a 30-patient trial tested 200, 400 and 800 mcg sprays against placebo. That was years before $VICP's proposed $2M deal. For $SLS followers, does prior clinical evidence change the risk?

$VICP $QQQ $SLS #Biotech

[Moch Farhan J @Ahanmahar]

Liquidity is everything on OTC, that 15x range is just noise without volume behind it

#BaddiesUSAChapter3

$RKLB $APPS

[Paul Washington @Pau_Was_48]

$VICP's Google Finance snapshot showed a $0.10–$1.50 52-week range and roughly 32.37M shares outstanding. A 15x range isn't a return anyone necessarily earned. For $RKLB traders, how much does OTC liquidity matter?

$VICP $QQQ $RKLB #Stocks

[Moch Farhan J @Ahanmahar]

That’s the part worth watching — if those Argentina talks move, the story gets a lot bigger.

#FursuitFriday

$APPS $QUBT

[Hope Page @cozzaliliana1]

Could $VICP take VICAPSYN beyond the U.S.? Its Nov 2 update mentions exploratory talks in Argentina for future clinical work. Pfizer once enrolled 4,000+ trial volunteers there, but VICP has no approved trial yet. What comes next?

$VICP $MU $CAPR #Biotech

[Moch Farhan J @Ahanmahar]

Liquidity absolutely matters, those falling volume days tell you more than the flat close does. Science alone won't move a thin tape.

#DUUUVAL

$SMCI $MARA

[Aria Cook @Akira06231931]

Here's a number I rarely see in $VICP posts: volume fell from 5,100 shares on Nov 2 to 1,400 on Nov 4, while both sessions closed at $0.50. For $CAPR traders, is the liquidity story as important as the science?

$VICP $MU $CAPR #OTCStocks

[Moch Farhan J @Ahanmahar]

Yeah that's just structural mechanics, not some hidden target. Good breakdown 👍

#Caturday

$QQQ $MARA

[Michael Taylor @sandebele55]

Why does $2.50 appear in $VICP filings? It's a VWAP threshold over 20 consecutive trading days for a possible issuer-triggered conversion of a $2M note. Not an analyst target. How would you assess that structure?

$VICP $QQQ $RKLB #OTCStocks

[Moch Farhan J @Ahanmahar]

For $HIMS followers thinking about healthcare access: $VICP says Stateline reaches all 50 states with a third-party logistics model, not 50 warehouses. The question isn't reach alone. Can 400 existing accounts translate into sales?

$VICP $QQQ $HIMS #Stocks

[Moch Farhan J @Ahanmahar]

Own product plus 400 accounts already in place is a solid setup if they close it. Watching $VICP too 👀

#bb28

$NET $SMCI

[Feather Santellana @FSantellan88579]

Here's why $VICP has me curious. They signed a $2M agreement to acquire NitroMist, a previously FDA-approved nitroglycerin spray, while their Stateline business already has around 400 healthcare accounts. If they complete the deal and successfully relaunch the product, they could be selling their own branded medicine through an established distribution network. That's a business model worth watching

[Moch Farhan J @Ahanmahar]

@ScrivenerB91486 Yeah named backers hit different than anon whales, makes the whole thing feel legit. Curious what else Dune's been in too